COMMUNIQUÉS West-GlobeNewswire

Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
08/07/2026
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimod Company unveils NEPTUNE ( N europathic E [...]
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
08/07/2026
Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”) today issued a letter to [...]
Shopify to Announce Second-Quarter 2026 Financial Results
08/07/2026
Internet, Everywhere, July 08, 2026 (GLOBE NEWSWIRE) -- Shopify Inc. (NASDAQ, TSX: SHOP) plans to announce financial results for the quarter ended June 30, 2026 before markets open on Wednesday, August 5, 2026. Shopify’ [...]
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment
08/07/2026
80% of SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the Investigator-Sponsored Trial (IST) conducted by Memorial Sloan Kettering Cancer Center [...]
Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247
08/07/2026
All four participants showed a decline in fat fraction as measured by MRI, with a mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesting improved muscle composition All four [...]
J-Star Holding Holding Co., Ltd Announces 1-for-5 Share Consolidation
08/07/2026
TAICHUNG CITY, Taiwan, July 08, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today announced that it plans to implement a 1-for-5 share consolidation of its Class A [...]
Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases
08/07/2026
Free platform empowers patients and families with information on 53 diseases, 125 genes, active clinical trials, treatment pipelines, and support resources GILBERT, Ariz., July 08, 2026 (GLOBE NEWSWIRE) -- Today, as co- [...]
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
08/07/2026
Kevin Norrett, a proven leader in advancing corporate strategy through value-creating transactions, will be appointed as Chief Business Officer Charles Carter promoted to Chief Financial Officer, reflecting his strong [...]
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08/07/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins
08/07/2026
NEURIED, Germany and NESLE, France, July 08, 2026 (GLOBE NEWSWIRE) -- AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe ( [...]
Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric
08/07/2026
Introducing Sleep Longevity: a new category of care that turns the world’s most overlooked health metric into action. Sleep better. Live longer. Miami, Florida, July 08, 2026 (GLOBE NEWSWIRE) -- Millions of people wake [...]
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
08/07/2026
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as Tensive approaches pivotal clinical and regulatory milestones for its [...]
On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper
08/07/2026
SHENZHEN, China, July 08, 2026 (GLOBE NEWSWIRE) -- WONDERLAB, a leading Chinese probiotics company ranked No.1 in probiotic sales in China,¹ has published the Targeted Microbiota Weight Management White Paper, a strain- [...]
Trimoryn Supplement Facts Analysis: Latest Safety Report Issued to Consumers About Ingredients' Effectiveness & Side Effects Risk
08/07/2026
Trimoryn issues a 2026 supplement facts and consumer safety update covering its weight management support formula, ingredient amounts, suggested use, side effects risk considerations, customer support details, and 60- [...]
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
08/07/2026
LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology [...]
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
08/07/2026
Novo Nordisk s’apprête à mener une évaluation interne non exclusive des implants à base de sémaglutide élaborés par Vivani ALAMEDA, Californie, 08 juill. 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq : VANI) (« [...]
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08/07/2026
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics [...]
TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
08/07/2026
TAIPEI, July 07, 2026 (GLOBE NEWSWIRE) -- TaiMed Biologics (TPEX: 4147) announced today that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) has officially received a Drug [...]

Pages